Evidence map›Paper›PMID 26909017›Full record

ArticleFrontiers in neuroscience2016

Ketamine-Based Anesthetic Protocols and Evoked Potential Monitoring: A Risk/Benefit Overview.

Nicoleta Stoicea, Gregory Versteeg, Diana Florescu, Nicholas Joseph, Juan Fiorda-Diaz, Víctor Navarrete, Sergio D Bergese

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Nicoleta StoiceaDepartment of Anesthesiology, The Ohio State University Wexner Medical Center Columbus, OH, USA.
Gregory VersteegCollege of Medicine, The Ohio State University Wexner Medical Center Columbus, OH, USA.
Diana FlorescuFaculty of Medicine, Carol Davila University of Medicine and Pharmacy Bucharest, Romania.
Nicholas JosephDepartment of Anesthesiology, The Ohio State University Wexner Medical CenterColumbus, OH, USA; Department of Neuroscience, The Ohio State UniversityColumbus, OH, USA.
Juan Fiorda-DiazDepartment of Anesthesiology, The Ohio State University Wexner Medical Center Columbus, OH, USA.
Víctor NavarreteServicio de Anestesiologia, Clínica Cira García La Habana, Cuba.
Sergio D BergeseDepartment of Anesthesiology, The Ohio State University Wexner Medical CenterColumbus, OH, USA; Department of Neurosurgery, The Ohio State University Wexner Medical CenterColumbus, OH, USA.
The Ohio State University Wexner Medical Center · USCarol Davila University of Medicine and Pharmacy · ROHospital Oncológico Docente "Conrado Benítez García" · CUThe Ohio State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since its discovery, ketamine, a non-competitive N-methyl D-aspartate (NMDA) receptor antagonist related to phencyclidine, has been linked to multiple adverse reactions sometimes described as "out of body" and "near death experiences," including emergence phenomena, delusions, hallucinations, delirium, and confusion. Due to these effects, ketamine has been withdrawn from mainstream anesthetic use in adult patients. Evoked potentials (EPs) are utilized to monitor neural pathways during surgery, detect intraoperative stress or damage, detect and define the level of neural lesions, and define abnormalities. Unfortunately, many of the volatile anesthetics commonly used during spinal and neurologic procedures suppress EP amplitude and monitoring. Ketamine has been found in several preclinical and clinical studies to actually increase EP amplitude and thus has been used as an analgesic adjunct in procedures where EP monitoring is critical. Once the gap in our knowledge of ketamine's risks has been sufficiently addressed in animal models, informed clinical trials should be conducted in order to properly incorporate ketamine-based anesthetic regimens during EP-monitored neurosurgeries.

Indexed as

drug abuseevoked potentialsgeneral anesthesiaketaminemotor evoked potentialsphencyclidinesomatosensory evoked potentials

Identifiers

PMID26909017
PMCPMC4754440
OpenAlexW2310442117

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.